# Abbott Spins Off Nutrition for Long-Term Growth

> Abbott spins off nutrition business to focus on high-margin medical tech and diagnostics.
- Title: Abbott Spins Off Nutrition for Long-Term Growth | Shortify
- Summary: Abbott spins off nutrition business to focus on high-margin medical tech and diagnostics. Abbott plans to spin off its nutrition division to boost medical…
- Keywords: abbott, nutrition, medical devices, diagnostics, spinning off, long-term investors, finance, money, Spins, Long-Term, Growth, The Motley Fool
- Source: The Motley Fool — https://fool.com/earnings/takeaways/2026/10/21/abbott-3-key-takeaways-for-long-term-investors
- Author: The Motley Fool Team
- Published: 2026-10-21T20:15:38+00:00
- Read time: 1 min
- Topics: abbott, nutrition, medical devices, diagnostics, spinning off, long-term investors, finance, money
## Spinning Off Nutrition Isolates High-Margin Healthcare Growth
Abbott plans to spin off its nutrition business into an independent public company on Oct 21, 2026.

> Separating adult and pediatric nutrition creates a pure-play consumer health business while shifting the remaining portfolio toward faster-growing medical devices and diagnostics.
## Cancer Diagnostics Drive Core Testing Revenue Acceleration
Cologuard and precision oncology tools boosted cancer diagnostics sales by 14% in Q3 2026.

> In cancer diagnostics, sales growth of 14% was driven by Cologuard and contributions to growth from our precision oncology and international businesses.
## Pulsed Field Ablation Powers Electrophysiology Expansion
New catheter technology and regulatory approvals accelerate electrophysiology market share gains.

> Growth was well-balanced across the portfolio, led by double-digit growth in electrophysiology and rhythm management.
## Spinning Off Nutrition Sharpens Corporate Focus
Spinning off nutrition boosts medical device sales and margins while preserving dividend continuity.

> Spinning off the nutrition division sharpens the corporate structure around high-margin technology, directing capital toward high-return medical research while preserving dividend continuity and balance sheet strength.
## Key takeaway

Abbott plans to spin off its nutrition division to boost medical device growth and margins for long-term investors.